Medical advocacy groups welcomed Johnson & Johnson's decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices after South African authorities investigated the conglomerate. The South African Competition Commission in a statement on July 5 said it decided not to prosecute a comp...